Hematopoietic neoplasm chemotherapy
AssigneeEli Lilly and Company
InventorMarcio Chedid
Life of this patent
Estimating the term…
Abstract
A method and medicament for treating mixed lineage leukemia; translocated mixed lineage leukemia; translocated mixed lineage leukemia based acute myelogenous leukemia; translocated mixed lineage leukemia based acute lymphoid leukemia; a non-MLL based chronic myeloproliferative disorder, or non-MLL based acute lymphoid leukemia is provided.
Claims1
A method of treating a patient suffering from a non-mixed lineage leukemia based chronic myeloproliferative disorder which is acute myelogenous leukemia comprising administering to a patient in need of treatment an effective amount of 7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)-pyrrolo[3,2,1-jk][1,4]benzodiazepine or pharmaceutically acceptable salt or solvate thereof.
Dependencies are inferred from the claim text.